Position in ARVN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,113,107
-$409,014 QoQ
Shares Held
615,296
+18.1% QoQ
Ownership
0.941%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,537,836 across 424 Biotechnology names. ARVN ranks #160 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ARVN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,113,107 | 615,296 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $5,522,121 | 520,955 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $6,493,015 | 547,472 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $5,105,343 | 599,219 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $4,125,668 | 560,553 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $4,043,820 | 576,043 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $12,098,779 | 631,131 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $14,494,581 | 588,493 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $13,199,392 | 495,845 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $21,016,762 | 509,127 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $20,219,231 | 491,235 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $9,380,003 | 477,597 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $11,483,791 | 462,683 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $12,268,699 | 449,074 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,134,434 | 442,398 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $19,565,321 | 439,769 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $18,398,336 | 437,119 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $29,346,971 | 436,062 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $37,066,248 | 451,257 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $36,556,045 | 444,829 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $33,472,439 | 434,707 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $25,784,021 | 390,076 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $33,263,001 | 391,652 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $7,852,826 | 332,606 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $8,798,345 | 262,324 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $10,686,148 | 265,165 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||